US Stock MarketDetailed Quotes

Pfizer (PFE)

Watchlist
  • 26.920
  • -0.300-1.10%
Close Apr 10 15:59 ET
  • 26.939
  • +0.019+0.07%
Post 19:59 ET
153.13BMarket Cap19.79P/E (TTM)

Pfizer (PFE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 28, 2025
(Q2)Jun 29, 2025
(Q1)Mar 30, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 28, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.15%11.71B
-20.39%5.35B
-31.43%4.6B
67.32%-582M
113.93%2.33B
46.44%12.74B
28.20%6.72B
94.13%6.71B
-47.31%-1.78B
-9.91%1.09B
Net income from continuing operations
-3.28%7.79B
-499.03%-1.64B
-20.75%3.55B
9,264.52%2.9B
-4.96%2.97B
270.50%8.05B
112.33%411M
287.65%4.48B
-98.68%31M
-43.69%3.13B
Depreciation and amortization
-6.00%6.59B
-5.81%1.69B
-5.30%1.66B
-6.12%1.63B
-6.80%1.62B
11.49%7.01B
7.25%1.79B
12.50%1.76B
10.04%1.73B
16.75%1.74B
Deferred tax
-1.47%-2.13B
-9.34%-433M
-58.71%-765M
65.26%-272M
-50.34%-663M
38.93%-2.1B
78.69%-396M
-326.55%-482M
10.31%-783M
26.25%-441M
Other non cash items
44.65%-1.26B
63.93%-487M
55.34%-376M
-175.18%-206M
46.74%-188M
46.95%-2.27B
56.03%-1.35B
-46.69%-842M
151.02%274M
-253.00%-353M
Change In working capital
-74.62%-5.35B
-45.66%1.59B
-104.10%-36M
-41.13%-4.99B
42.48%-1.92B
-41.16%-3.07B
-65.37%2.93B
173.31%879M
9.73%-3.54B
39.42%-3.34B
-Change in receivables
-141.28%-263M
----
----
----
----
-131.41%-109M
----
----
----
----
-Change in inventory
165.69%561M
----
----
----
----
26.95%-854M
----
----
----
----
-Change in payables and accrued expense
54.15%-469M
----
----
----
----
-241.00%-1.02B
----
----
----
----
-Change in other current assets
-61.86%1.29B
----
----
----
----
609.80%3.38B
----
----
----
----
-Change in other current liabilities
-17.72%-3.67B
----
----
----
----
-623.53%-3.12B
----
----
----
----
-Change in other working capital
-108.55%-2.81B
----
----
----
----
-36.97%-1.35B
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-8.16%11.7B
-20.43%5.35B
-31.44%4.6B
67.32%-582M
114.22%2.34B
46.48%12.74B
28.26%6.72B
94.27%6.71B
-47.43%-1.78B
-10.07%1.09B
Investing cash flow
Cash flow from continuing investing activities
-150.90%-1.35B
-279.38%-6.15B
-17.98%-2.43B
-14.19%3.95B
89.20%3.28B
108.22%2.65B
85.27%-1.62B
-331.24%-2.06B
118.05%4.6B
-47.80%1.73B
Net PPE purchase and sale
9.63%-2.63B
7.85%-845M
7.53%-602M
2.98%-618M
19.89%-564M
25.54%-2.91B
12.16%-917M
19.63%-651M
30.31%-637M
38.19%-704M
Net business purchase and sale
-108.75%-616M
-295.18%-6.93B
--0
--0
80.78%6.31B
116.21%7.04B
108.18%3.55B
--0
--0
--3.49B
Net investment purchase and sale
216.90%1.73B
141.32%1.76B
-30.31%-1.84B
-12.90%4.58B
-162.50%-2.77B
-109.71%-1.48B
-112.76%-4.27B
-204.59%-1.41B
121.88%5.26B
-123.61%-1.06B
Net other investing changes
--165M
---137M
100.00%12M
52.63%-9M
29,800.00%299M
----
----
-98.28%6M
96.37%-19M
105.26%1M
Cash from discontinued investing activities
Investing cash flow
-150.94%-1.35B
-278.68%-6.15B
-18.13%-2.43B
-14.11%3.95B
89.03%3.27B
108.22%2.65B
85.24%-1.62B
-331.64%-2.06B
118.05%4.6B
-47.75%1.73B
Financing cash flow
Cash flow from continuing financing activities
39.89%-10.3B
111.67%597M
46.59%-2.48B
-30.01%-3.2B
-6.00%-5.23B
-165.75%-17.14B
-193.97%-5.11B
-22.68%-4.64B
-109.05%-2.46B
-77.95%-4.93B
Net issuance payments of debt
98.97%-74M
213.42%3.09B
100.27%6M
-4,468.75%-731M
-12.01%-2.43B
-119.92%-7.16B
-134.98%-2.72B
-57.56%-2.25B
-100.05%-16M
-6,690.63%-2.17B
Net common stock issuance
----
----
----
----
----
--0
----
----
----
----
Cash dividends paid
-2.72%-9.77B
-2.73%-2.45B
-2.69%-2.44B
-2.73%-2.45B
-2.74%-2.44B
-2.87%-9.51B
-2.81%-2.38B
-2.85%-2.38B
-2.81%-2.38B
-3.00%-2.37B
Net other financing activities
2.13%-459M
-214.29%-44M
-550.00%-39M
68.25%-20M
7.77%-356M
25.79%-469M
22.22%-14M
83.78%-6M
55.32%-63M
11.47%-386M
Cash from discontinued financing activities
Financing cash flow
39.88%-10.3B
111.65%596M
46.57%-2.48B
-29.97%-3.2B
-6.00%-5.23B
-165.76%-17.14B
-193.97%-5.11B
-22.68%-4.64B
-109.05%-2.46B
-77.95%-4.93B
Net cash flow
Beginning cash position
-62.05%1.11B
21.01%1.39B
50.85%1.69B
89.87%1.48B
-62.05%1.11B
523.29%2.92B
-64.37%1.15B
-58.38%1.12B
-64.90%780M
523.29%2.92B
Current changes in cash
102.81%49M
-1,162.50%-202M
-1,610.00%-302M
-52.35%172M
118.07%381M
-170.07%-1.74B
94.92%-16M
-96.47%20M
-24.95%361M
-220.10%-2.11B
Effect of exchange rate changes
162.12%41M
117.24%5M
-77.78%2M
327.78%41M
75.00%-7M
-65.00%-66M
-2,800.00%-29M
128.13%9M
-260.00%-18M
-1,300.00%-28M
End cash Position
8.13%1.2B
8.13%1.2B
21.01%1.39B
50.85%1.69B
89.87%1.48B
-62.05%1.11B
-62.05%1.11B
-64.37%1.15B
-58.38%1.12B
-64.90%780M
Free cash flow
-7.73%9.08B
-22.42%4.5B
-34.01%4B
50.37%-1.2B
358.81%1.77B
105.20%9.84B
38.32%5.8B
129.14%6.06B
-13.95%-2.42B
428.77%386M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 28, 2025(Q2)Jun 29, 2025(Q1)Mar 30, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 28, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.15%11.71B-20.39%5.35B-31.43%4.6B67.32%-582M113.93%2.33B46.44%12.74B28.20%6.72B94.13%6.71B-47.31%-1.78B-9.91%1.09B
Net income from continuing operations -3.28%7.79B-499.03%-1.64B-20.75%3.55B9,264.52%2.9B-4.96%2.97B270.50%8.05B112.33%411M287.65%4.48B-98.68%31M-43.69%3.13B
Depreciation and amortization -6.00%6.59B-5.81%1.69B-5.30%1.66B-6.12%1.63B-6.80%1.62B11.49%7.01B7.25%1.79B12.50%1.76B10.04%1.73B16.75%1.74B
Deferred tax -1.47%-2.13B-9.34%-433M-58.71%-765M65.26%-272M-50.34%-663M38.93%-2.1B78.69%-396M-326.55%-482M10.31%-783M26.25%-441M
Other non cash items 44.65%-1.26B63.93%-487M55.34%-376M-175.18%-206M46.74%-188M46.95%-2.27B56.03%-1.35B-46.69%-842M151.02%274M-253.00%-353M
Change In working capital -74.62%-5.35B-45.66%1.59B-104.10%-36M-41.13%-4.99B42.48%-1.92B-41.16%-3.07B-65.37%2.93B173.31%879M9.73%-3.54B39.42%-3.34B
-Change in receivables -141.28%-263M-----------------131.41%-109M----------------
-Change in inventory 165.69%561M----------------26.95%-854M----------------
-Change in payables and accrued expense 54.15%-469M-----------------241.00%-1.02B----------------
-Change in other current assets -61.86%1.29B----------------609.80%3.38B----------------
-Change in other current liabilities -17.72%-3.67B-----------------623.53%-3.12B----------------
-Change in other working capital -108.55%-2.81B-----------------36.97%-1.35B----------------
Cash from discontinued investing activities
Operating cash flow -8.16%11.7B-20.43%5.35B-31.44%4.6B67.32%-582M114.22%2.34B46.48%12.74B28.26%6.72B94.27%6.71B-47.43%-1.78B-10.07%1.09B
Investing cash flow
Cash flow from continuing investing activities -150.90%-1.35B-279.38%-6.15B-17.98%-2.43B-14.19%3.95B89.20%3.28B108.22%2.65B85.27%-1.62B-331.24%-2.06B118.05%4.6B-47.80%1.73B
Net PPE purchase and sale 9.63%-2.63B7.85%-845M7.53%-602M2.98%-618M19.89%-564M25.54%-2.91B12.16%-917M19.63%-651M30.31%-637M38.19%-704M
Net business purchase and sale -108.75%-616M-295.18%-6.93B--0--080.78%6.31B116.21%7.04B108.18%3.55B--0--0--3.49B
Net investment purchase and sale 216.90%1.73B141.32%1.76B-30.31%-1.84B-12.90%4.58B-162.50%-2.77B-109.71%-1.48B-112.76%-4.27B-204.59%-1.41B121.88%5.26B-123.61%-1.06B
Net other investing changes --165M---137M100.00%12M52.63%-9M29,800.00%299M---------98.28%6M96.37%-19M105.26%1M
Cash from discontinued investing activities
Investing cash flow -150.94%-1.35B-278.68%-6.15B-18.13%-2.43B-14.11%3.95B89.03%3.27B108.22%2.65B85.24%-1.62B-331.64%-2.06B118.05%4.6B-47.75%1.73B
Financing cash flow
Cash flow from continuing financing activities 39.89%-10.3B111.67%597M46.59%-2.48B-30.01%-3.2B-6.00%-5.23B-165.75%-17.14B-193.97%-5.11B-22.68%-4.64B-109.05%-2.46B-77.95%-4.93B
Net issuance payments of debt 98.97%-74M213.42%3.09B100.27%6M-4,468.75%-731M-12.01%-2.43B-119.92%-7.16B-134.98%-2.72B-57.56%-2.25B-100.05%-16M-6,690.63%-2.17B
Net common stock issuance ----------------------0----------------
Cash dividends paid -2.72%-9.77B-2.73%-2.45B-2.69%-2.44B-2.73%-2.45B-2.74%-2.44B-2.87%-9.51B-2.81%-2.38B-2.85%-2.38B-2.81%-2.38B-3.00%-2.37B
Net other financing activities 2.13%-459M-214.29%-44M-550.00%-39M68.25%-20M7.77%-356M25.79%-469M22.22%-14M83.78%-6M55.32%-63M11.47%-386M
Cash from discontinued financing activities
Financing cash flow 39.88%-10.3B111.65%596M46.57%-2.48B-29.97%-3.2B-6.00%-5.23B-165.76%-17.14B-193.97%-5.11B-22.68%-4.64B-109.05%-2.46B-77.95%-4.93B
Net cash flow
Beginning cash position -62.05%1.11B21.01%1.39B50.85%1.69B89.87%1.48B-62.05%1.11B523.29%2.92B-64.37%1.15B-58.38%1.12B-64.90%780M523.29%2.92B
Current changes in cash 102.81%49M-1,162.50%-202M-1,610.00%-302M-52.35%172M118.07%381M-170.07%-1.74B94.92%-16M-96.47%20M-24.95%361M-220.10%-2.11B
Effect of exchange rate changes 162.12%41M117.24%5M-77.78%2M327.78%41M75.00%-7M-65.00%-66M-2,800.00%-29M128.13%9M-260.00%-18M-1,300.00%-28M
End cash Position 8.13%1.2B8.13%1.2B21.01%1.39B50.85%1.69B89.87%1.48B-62.05%1.11B-62.05%1.11B-64.37%1.15B-58.38%1.12B-64.90%780M
Free cash flow -7.73%9.08B-22.42%4.5B-34.01%4B50.37%-1.2B358.81%1.77B105.20%9.84B38.32%5.8B129.14%6.06B-13.95%-2.42B428.77%386M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More